Analysis of glycolytic flux as a rapid screen to identify low lactate producing CHO cell lines with desirable monoclonal antibody yield and glycan profile by Legmann, Rachel et al.
MEETING ABSTRACT Open Access
Analysis of glycolytic flux as a rapid screen to
identify low lactate producing CHO cell lines with
desirable monoclonal antibody yield and glycan
profile
Rachel Legmann
1*, Julie Melito
1, Ilana Belzer
2, David Ferrick
1
From 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies
Vienna, Austria. 15-18 May 2011
Background
In CHO cell lines currently selected for the production
of recombinant antibody, approximately 80% of the
metabolized glucose is converted into lactic acid. These
cells with a glycolytic phenotype exhibit significantly
higher rates of proton production (extracellular acidifi-
cation rate, ECAR) from lactate production than cells
using oxidative phosphorylation (oxygen consumption
rate, OCR). Therefore, shifts in the cell’s metabolism
can be detected conveniently and dynamically through
simultaneous detection of ECAR and OCR. Such mea-
surements can characterize the metabolic programming
of individual cell types and forecast the quality potential
of their produced glycoproteins. In this study, we uti-
lized an XF96 analyzer to measure glycolysis and mito-
chondrial respiration simultaneously, and in real-time.
This allows one to determine the response of these two
pathways to ATP demand, and indirectly, biosynthetic
needs. A rapid screen was performed to determine the
desired lactic acid production by exposing the cells to
alternate sources of substrates, such as galactose or fruc-
tose. Specific metrics of the study included cell growth,
product yield, and glycan profile. Higher titer, viable cell
density, and viability along with glycol-similarity were
observed for galactose and glutamine feeding strategies
during the production phase. We believe this rapid, cell
based metabolic screen that is label-free and non-inva-
sive can be used to identify low lactic acid CHO mAb
cell producers in both batch and fed-batch systems.
This selection is accomplished without compromising
clone productivity and product quality.
Material and methods
Suspended CHO cells producing a recombinant IgG
monoclonal antibody (MAb) were maintained in high
glucose serum free chemically-defined (CD) CHO sup-
plemented with 0.2μM methotrexate (MTX). The low-
buffered DMEM assay medium was used for XF96
ECAR screening and CD CHO medium was used for
fed-batch flasks for lactic acid screening. Mitochondrial
function and cellular bioenergetics were measured in
intact CHO_mAb using a Seahorse Bioscience extracel-
lular flux analyzer (XF96) as described previously (1, 3)
and demonstrated in Figure 1. The sensor cartridge is
embedded with 96 dual florescent biosensors (O and H
+). Each sensor cartridge is also equipped delivery ports
for injecting agents during an assay. Cells were main-
tained in a 5% CO2 incubator at 37 °C and 1 h before
the experiment, cells were washed and incubated in
nonbuffered (without sodium carbonate) DMEM (sugar-
free) pH 7.4, at 37 °C in a non-CO2 incubator. Real
time cellular ECAR and OCR were measured simulta-
n e o u s l yb e f o r ea n da f t e rt h es u b s t r a t es o u r c ei n j e c t i o n .
The metabolic rate of the cell population was measured
repeatedly over about 30 min. Lactic acid concentrations
in the flasks were measured after different carbon
sources were added to the cells after 5 days of growth
and glucose depletion during the production phase
using a NOVA BioProfile 100 Plus. MAb concentrations
in samples from flasks were quantified using Octet
QK
instrument with protein A biosensors. Glycan profile in
crude harvest samples from flasks were quantified using
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described previously(2).
The illustration demonstrates how the XF96 measures
changes in the microenvironment (3μl) surrounding live
cells in a 96-well microplate. The O2 and proton con-
centration is determined by a quenching reaction of a
fluorophore specific for O2 (blue) or protons (red) that
is embedded into a single polymer martix on the biosen-
sor cartridge.
Results
Mammalian cells in culture have inefficient glucose
metabolism where most of the glucose consumed is
converted into lactate, while very little is oxidized in the
tricarboxylic acid cycle (TCA).One of the interpretation
for this phenomenon of high glycolysis rate even under
fully aerobic condition is that lactate generation from
pyruvate may be used by these cells as a way to re-equi-
librate their redox potential. The high glycolysis rates
would generate NADH at high rates, which should be
reduced to NAD in order to keep this pathway func-
tional. In Figure 2(A), metabolic analyses from this
study demonstrate that different carbon and nitrogen
sources added during the product production phase can
promote or diminish aerobic glycolysis as indicated by
ECAR. The data show that ECAR correlates well with
glycolysis driving lactic acid synthesis in the recombi-
nant CHO_mAb cells. The highest lactic acid concentra-
tion and ECAR were obtained when glucose was present
in the medium as the sole carbon source. The lowest
lactic acid and ECAR were obtained when galacose or
fructose was present in the media during the glycopro-
tein production phase. Therefore, adding galactose or
fructose when glucose becomes depleted at the end of
the growth phase would provide an alternative carbon
source to drive low-waste lactic acid production. The
rapid method developed in this study identified the opti-
mum carbon and nitrogen source that achieved less
than 77% proton production compared to glucose while
maintaining optimal and consistent protein glycosyla-
tion. Metabolic shift to aerobic glycolysis was observed
when glucose or mannose was injected into the CHO_-
mAb cell cultures as shown in Figure 2B. XF analyses
demonstrated that cells consuming glucose or mannose
are diverted toward glycolysis even in the presence of
sufficient levels of dissolved oxygen. Good correlation
was observed between ECAR and accumulation of lactic
acid in Erlenmeyer flasks (Figure 2C).
Conclusions
In this study, we developed and validated a rapid assay,
employing the XF96 analyzer, to screen for low ECAR
Figure 1 Seahorse XF analyzer measure the two ATP generating pathways of the cell. The cell is consuming oxygen, producing CO2 and
excreting (H+) protons that acidify the media.
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The experiments show that there is a good agreement
between ECAR and lactic acid and therefore ECAR can
be rapidly measured as an index of glycolytic activity
and serve as an accurate surrogate of lactate production.
The data show that alternating carbon sugars during the
production phase ,such as galactose and fructose, can
help to control glycolysis and, therefore, reduce the lac-
tate accumulation in mammalian cell cultures without
compromising on recombinant glycoprotein productivity
and desired glycoform profile.
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Figure 2 The effect of different carbon sources on ECAR from lactic acid production and on metabolic shift in CHO_mAb. Change of baseline
ECAR of CHO_mAb cells after Carbon/nitrogen source injection versus time (A). Glucose and mannose preference for aerobic glycolysis(B)
Comparison of maximum ECAR in XF96 with lactic acid in shake flasks showed an excellent correlation, R
2=0.91 (C)
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